Purchase Order 75H71122P00945
- Not listed
- This federal contract award was issued by the Indian Health Service (IHS), a civilian agency, to Abbott Laboratories for the provision of lab reagents and consumables. The $166,699.42 firm fixed-price purchase order has an ultimate completion date of April 30, 2021 and was awarded on December 23, 2016. The contract does not have a set-aside designation. Abbott Laboratories is a global healthcare company that supplies a wide range of medical devices, diagnostics, and other products to various...
- This is a $69,759.00 firm fixed-price purchase order contract awarded by the Indian Health Service (IHS) to Abbott Rapid Diagnostics Informatics, Inc., a subsidiary of Abbott Laboratories. The contract is for 24-GIMC laboratory services, with a period of performance from May 20, 2024 to May 19, 2025, and an ultimate completion date of May 19, 2029. The contract is not set aside for small businesses. Abbott Rapid Diagnostics Informatics, Inc. is a vendor that specializes in providing healthcare...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract, valued at $12,060.60, is for the delivery of medical supplies. The period of performance runs through February 1, 2024. This award does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, in vitro...
- This is a firm fixed-price purchase order awarded by the U.S. Bureau of Administration (a civilian federal agency) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the delivery of medical supplies. The contract has a ceiling value of $12,462.40 and a completion date of June 22, 2024. It is not designated as a set-aside award. The award is associated with Abbott Rapid DX North America LLC's existing federal contract vehicles, including a Blanket Purchase Agreement...
- This is a federal contract award from the Indian Health Service, a civilian agency, to Abbott Laboratories Inc. for $112,733.15. The contract is a delivery order under Abbott's existing General Services Administration Federal Supply Schedule contract for Critical Analyzers, Laboratory. The contract is for an unspecified set of goods and services related to "ABBOTT LABS COST-PER-TEST***", likely clinical laboratory testing and associated equipment and consumables. The award has no...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian agency within the U.S. government, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $12,360.00 contract is for the delivery of medical supplies, with a final completion date of June 27, 2025. The contract is not set aside for any specific business category. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic equipment, including rapid...
- This is a $13,066 firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian federal agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of medical supplies, with a period of performance through June 2024. This award is not set aside for any socioeconomic program. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to various...
- This is a fixed-price purchase order awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the delivery of medical supplies. The contract has a ceiling value of $11,577.60 and a completion date of June 15, 2024. It is not associated with a set-aside program. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to government agencies such as the...
- This is a federal contract award to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide medical supplies for the U.S. government. The contract, valued at $10,707.00, is a firm fixed-price purchase order awarded by the Bureau of Administration, a civilian agency. The award has no set-aside designation and has an ultimate completion date of March 20, 2025. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen...
- This is a $16,875.00 firm-fixed price purchase order contract awarded to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by the Bureau of Administration, a civilian federal agency. The contract is for the delivery of medical supplies, with a completion date of January 12, 2024. It does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to various government agencies,...
This is a $55,520,466.00 Firm Fixed Price purchase order awarded by the Indian Health Service to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract provides laboratory analyzers, testing kits/reagents, associated peripherals, and related support and service agreements to effectively test for COVID-19 specimens, as well as other samples and cultures. This award does not have a small business set-aside designation. The contract is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle that allows the Indian Health Service to order these medical diagnostic products and services on an as-needed basis. Abbott Laboratories, the parent company of the awardee, is a global healthcare company that has supplied the Department of Veterans Affairs and other federal agencies with a variety of medical devices, diagnostic equipment, and COVID-19 testing supplies during the pandemic. The contract has a period of performance through September 2023.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($109) | 8/24/23 | |
| Not listed | Not listed | $55.5m | 9/23/22 |